VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 492 filers reported holding VANECK VECTORS ETF TR in Q3 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,012,770 | -12.5% | 223,440 | -2.1% | 2.10% | -7.7% |
| Q2 2023 | $6,873,812 | -7.6% | 228,290 | -0.7% | 2.27% | -9.4% |
| Q1 2023 | $7,436,942 | +12.7% | 229,890 | -0.2% | 2.51% | +6.2% |
| Q4 2022 | $6,599,858 | +24.8% | 230,281 | +5.0% | 2.36% | +19.2% |
| Q3 2022 | $5,289,000 | -10.9% | 219,275 | +1.1% | 1.98% | -3.0% |
| Q2 2022 | $5,937,000 | -27.8% | 216,835 | +1.1% | 2.04% | -12.4% |
| Q1 2022 | $8,222,000 | +34.2% | 214,395 | +12.1% | 2.33% | +35.2% |
| Q4 2021 | $6,126,000 | +10.0% | 191,265 | +1.2% | 1.72% | +4.2% |
| Q3 2021 | $5,567,000 | -6.3% | 188,910 | +8.1% | 1.66% | -4.7% |
| Q2 2021 | $5,940,000 | +11.0% | 174,815 | +6.2% | 1.74% | +0.6% |
| Q1 2021 | $5,350,000 | +9.2% | 164,605 | +21.0% | 1.73% | +3.8% |
| Q4 2020 | $4,898,000 | +13.0% | 135,985 | +22.9% | 1.66% | -0.4% |
| Q3 2020 | $4,333,000 | -3.1% | 110,655 | -9.3% | 1.67% | -10.0% |
| Q2 2020 | $4,473,000 | +62.5% | 121,955 | +2.1% | 1.85% | +27.4% |
| Q1 2020 | $2,753,000 | -15.9% | 119,495 | +6.9% | 1.46% | -3.3% |
| Q4 2019 | $3,273,000 | +31.4% | 111,795 | +19.9% | 1.50% | +18.2% |
| Q3 2019 | $2,490,000 | +8.9% | 93,220 | +4.2% | 1.27% | +8.7% |
| Q2 2019 | $2,286,000 | +4.2% | 89,445 | -8.6% | 1.17% | +4.7% |
| Q1 2019 | $2,194,000 | +10.8% | 97,845 | +4.2% | 1.12% | -4.1% |
| Q4 2018 | $1,981,000 | +22.3% | 93,945 | +7.4% | 1.17% | +37.0% |
| Q3 2018 | $1,620,000 | -7.5% | 87,450 | +11.3% | 0.85% | -17.8% |
| Q2 2018 | $1,752,000 | +8.4% | 78,550 | +6.8% | 1.04% | +4.2% |
| Q1 2018 | $1,616,000 | +16.5% | 73,525 | +23.2% | 0.99% | +15.5% |
| Q4 2017 | $1,387,000 | +48.7% | 59,700 | +47.0% | 0.86% | +39.2% |
| Q3 2017 | $933,000 | +84.0% | 40,625 | +77.0% | 0.62% | +82.8% |
| Q2 2017 | $507,000 | +92.8% | 22,950 | +98.7% | 0.34% | +78.8% |
| Q1 2017 | $263,000 | +8.7% | 11,550 | 0.0% | 0.19% | -2.6% |
| Q4 2016 | $242,000 | – | 11,550 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |